An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Acute Pain With Surgical or Non-Surgical Origin
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Adneuris Therapeutics, Inc.
- Study ID
- NCT07845071
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Pain
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Cebranopadol 400 ug — DRUGParticipants receive Cebranopadol 400 mcg once per day for 14 days or until pain resolves, whichever occurs first.
Study Details
The purpose of this study is to evaluate the safety and effectiveness of cebranopadol in treating acute pain.
Key Dates
- First listed
- Sep 28, 2026
- Start date
- Sep 22, 2026
- Status verified
- Oct 2026
- Primary completion
- Jan 31, 2027
- Completion
- Feb 28, 2027
Study Design
- Enrollment
- 160 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: CebranopadolParticipants receive Cebranopadol 400 µg Starting dose 400 mcg once per day for 14 days or until pain resolves, whichever occurs first.
Primary Outcome Measure
Sum of pain intensity differences through 48 hours (SPID48) [ Time Frame: From 0 through 48 hours ]
Central Contacts
- Study Director, Adneuris Therapeutics732-940-2800
- Emilio Quetglas, MD732-940-2800
Locations (15)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Adneuris Site 001115 | Phoenix | Arizona | 85053 | - |
| Adneuris Site 001118 | Riverside | California | 92504 | - |
| Adneuris Site 001119 | Longmont | Colorado | 80501 | - |
| Adneuris Site 001122 | Savannah | Georgia | 31406 | - |
| Adneuris Site 001123 | O'Fallon | Illinois | 62269 | - |
| Adneuris Site 001125 | Annapolis | Maryland | 21401 | - |
| Adneuris Site 001120 | Oradell | New Jersey | 07649 | - |
| Adneuris Site 001124 | Tulsa | Oklahoma | 74137 | - |
| Adneuris Site 001110 | Bellaire | Texas | 77401 | - |
| Adneuris Site 001117 | Forney | Texas | 75126 | - |
| Adneuris Site 001104 | McAllen | Texas | 78501 | - |
| Adneuris Site 001116 | Plano | Texas | 75093 | - |
| Adneuris Site 001111 | San Antonio | Texas | 78240 | - |
| Adneuris Site 001121 | San Antonio | Texas | 78240 | - |
| Adneuris Site 001101 | Salt Lake City | Utah | 84107 | - |
Find similar trials in Phoenix, AZ
Related Studies
- Psychophysical Studies of Cancer Therapy PainRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for PainRecruiting · Boston Scientific Corporation · Greenwood Village, Colorado
- Neural and Psychological Mechanisms of Pain PerceptionRecruiting · National Center for Complementary and Integrative Health (NCCIH) · Bethesda, Maryland
- Clinical and Scientific Assessment of Pain and Painful DisordersRecruiting · National Center for Complementary and Integrative Health (NCCIH) · Bethesda, Maryland